There were 68/110 (62%) PBC patients with at least one abnormality of their liver biochemistry (ALP, ALT, or bilirubin) but there was no statistically significant difference in serum allopregnanolone when grouped by “abnormal” or “normal” liver function tests (Table 4). The gene discussed is GPT; the disease is primary biliary cholangitis.